+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lacrimal Duct Stent Tubes - Global Strategic Business Report

  • PDF Icon

    Report

  • 283 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5994441
The global market for Lacrimal Duct Stent Tubes was estimated at US$40.0 Million in 2023 and is projected to reach US$46.5 Million by 2030, growing at a CAGR of 2.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Lacrimal duct stent tubes are medical devices used to treat conditions related to the lacrimal system, which is responsible for the drainage of tears from the eye into the nasal cavity. These stent tubes are particularly used in cases where the natural tear ducts are blocked, causing excessive tearing and discomfort, a condition known as dacryocystitis. Lacrimal duct stent tubes help to restore the proper flow of tears by opening up the blocked ducts. The procedure for inserting these tubes, typically a minimally invasive surgery known as dacryocystorhinostomy, involves creating a new route for tears to pass from the lacrimal sac into the nose. The stents are usually made from silicone and are designed to be biocompatible and flexible, which minimizes the risk of irritation and allows them to be in place for extended periods if necessary.

The design and manufacturing of lacrimal duct stent tubes have seen significant advancements over the years. Modern stent tubes are more effective and comfortable for patients, incorporating features that reduce the risk of infection and increase the longevity of the device's functionality. Recent developments include the use of drug-eluting stents, which slowly release medications to prevent inflammation or infection directly at the site of implantation. Additionally, improvements in the imaging technologies used during insertion procedures, such as endoscopic techniques, have enhanced the precision and safety of the surgery, leading to better outcomes and shorter recovery times for patients. These technological advancements not only improve patient comfort and procedure success rates but also contribute to the overall efficiency of treatments for tear duct obstructions.

The growth in the lacrimal duct stent tubes market is driven by several factors, including increasing prevalence of lacrimal system disorders, technological advancements in stent design and surgery, and a growing preference for minimally invasive surgical procedures. As populations age, the incidence of conditions like dry eye and other tear duct abnormalities increases, creating a higher demand for effective treatment solutions such as stenting. Technological innovations that enhance the safety and efficacy of lacrimal duct surgeries and stent implementations are key to this market's expansion. Additionally, as consumer awareness of available treatment options grows, more patients are likely to opt for procedures that promise quicker recovery and fewer complications, such as those involving advanced stent tubes. Furthermore, improvements in healthcare infrastructure and increased healthcare spending globally enable greater access to such specialized medical treatments, supporting the growth of the lacrimal duct stent market. Together, these factors are propelling the adoption of lacrimal duct stents as a standard treatment for relevant ophthalmic conditions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Bicanalicular Tubes segment, which is expected to reach US$35.0 Million by 2030 with a CAGR of a 2.4%. The Monocanalicular Tubes segment is also set to grow at 1.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $10.9 Million in 2023, and China, forecasted to grow at an impressive 4.5% CAGR to reach $9.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Lacrimal Duct Stent Tubes Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Lacrimal Duct Stent Tubes Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Lacrimal Duct Stent Tubes Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as BVI Medical, FCI Ophthalmics, Gunther Weiss Scientific Glassblowing Co., Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 46 Featured):

  • BVI Medical
  • FCI Ophthalmics
  • Gunther Weiss Scientific Glassblowing Co., Inc.
  • Kaneka Medical America LLC
  • Medline Industries, LP.
  • Surtex Instruments
  • Walsh Medical Devices Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Lacrimal Duct Stent Tubes - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Dacryostenosis Drives Market Growth
  • Increasing Focus on Minimally Invasive Procedures Strengthens Business Case
  • Expansion of Pediatric and Geriatric Patient Base Spurs Market Demand
  • Growing Awareness of Eye Health and Treatments Expands Addressable Market Opportunity
  • Innovations in Stent Tube Materials and Design Generate New Market Opportunities
  • Increasing Adoption in Ambulatory Surgery Centers Propels Market Growth
  • Expansion of Health Insurance Coverage Strengthens Market Adoption
  • Growing Trend of Office-Based Procedures Bodes Well for Market Expansion
  • Growth of the Aging Population Sets the Stage for Market Expansion
  • Increasing Use of Biocompatible Materials Generates New Opportunities
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Lacrimal Duct Stent Tubes Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Lacrimal Duct Stent Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Lacrimal Duct Stent Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Bicanalicular Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Bicanalicular Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Bicanalicular Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Monocanalicular Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Monocanalicular Tubes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Monocanalicular Tubes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Ophthalmic Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Ophthalmic Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Ophthalmic Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 43: China 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 46: China 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Lacrimal Duct Stent Tubes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Lacrimal Duct Stent Tubes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 58: France 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 59: France Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 61: France 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 77: UK Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
  • TABLE 80: Spain Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 82: Spain 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 85: Spain 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
  • TABLE 86: Russia Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 88: Russia 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 91: Russia 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 94: Rest of Europe 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 97: Rest of Europe 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Lacrimal Duct Stent Tubes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Lacrimal Duct Stent Tubes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Lacrimal Duct Stent Tubes by Tube Type - Bicanalicular Tubes and Monocanalicular Tubes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Lacrimal Duct Stent Tubes by Tube Type - Percentage Breakdown of Value Sales for Bicanalicular Tubes and Monocanalicular Tubes for the Years 2014, 2024 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Lacrimal Duct Stent Tubes by End-Use - Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Lacrimal Duct Stent Tubes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Lacrimal Duct Stent Tubes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BVI Medical
  • FCI Ophthalmics
  • Gunther Weiss Scientific Glassblowing Co., Inc.
  • Kaneka Medical America LLC
  • Medline Industries, LP.
  • Surtex Instruments
  • Walsh Medical Devices Inc.

Table Information